Form 8-K - Current report:
SEC Accession No. 0000950170-25-104020
Filing Date
2025-08-06
Accepted
2025-08-06 16:10:35
Documents
12
Period of Report
2025-08-06
Items
Item 2.02: Results of Operations and Financial Condition
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K asmb-20250806.htm   iXBRL 8-K 53407
2 EX-99.1 asmb-ex99_1.htm EX-99.1 299732
3 EX-99.2 asmb-ex99_2.htm EX-99.2 25042
  Complete submission text file 0000950170-25-104020.txt   505925

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT asmb-20250806.xsd EX-101.SCH 26016
14 EXTRACTED XBRL INSTANCE DOCUMENT asmb-20250806_htm.xml XML 4710
Mailing Address TWO TOWER PLACE 7TH FLOOR SOUTH SAN FRANCISCO CA 94080
Business Address TWO TOWER PLACE 7TH FLOOR SOUTH SAN FRANCISCO CA 94080 (833) 409-4583
ASSEMBLY BIOSCIENCES, INC. (Filer) CIK: 0001426800 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35005 | Film No.: 251189646
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)